Celebrex Approved to Treat Juvenile Rheumatoid Arthritis The U.S. Food
Celebrex Approved to Treat Juvenile Rheumatoid Arthritis
The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older.